Cargando…
Systemic inflammation impairs microglial Aβ clearance through NLRP3 inflammasome
Alzheimer's disease is the most prevalent type of dementia and is caused by the deposition of extracellular amyloid‐beta and abnormal tau phosphorylation. Neuroinflammation has emerged as an additional pathological component. Microglia, representing the brain's major innate immune cells, p...
Autores principales: | Tejera, Dario, Mercan, Dilek, Sanchez‐Caro, Juan M, Hanan, Mor, Greenberg, David, Soreq, Hermona, Latz, Eicke, Golenbock, Douglas, Heneka, Michael T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717897/ https://www.ncbi.nlm.nih.gov/pubmed/31359456 http://dx.doi.org/10.15252/embj.2018101064 |
Ejemplares similares
-
Immediate and long-term consequences of COVID-19 infections for the development of neurological disease
por: Heneka, Michael T., et al.
Publicado: (2020) -
Recent insights into the molecular mechanisms of the NLRP3
inflammasome activation
por: Próchnicki, Tomasz, et al.
Publicado: (2016) -
How location and cellular signaling combine to activate the NLRP3 inflammasome
por: Akbal, Anil, et al.
Publicado: (2022) -
NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice
por: Heneka, Michael T., et al.
Publicado: (2012) -
Membrane fusogenic lysine type lipid assemblies possess enhanced NLRP3 inflammasome activation potency
por: He, Jieyan, et al.
Publicado: (2019)